Integrity of Randomized Clinical Trials
Language: English
Published by Taylor and Francis Ltd, GB, 2024
- Softcover
- New

Seller: Rarewaves USA, HEBRON, KY, U.S.A.Rarewaves USA
AbeBooks seller since June 10, 2025
Condition: New
US$ 66.39
Quantity: 2 available
Add to basketItem description from seller
Today, scientists are expected to be more accountable and transparent than at any other time in history. Globally, the pursuit of knowledge creation enjoys a place of distinction, and the public expects to reap considerable benefits from the innovative contributions made by researchers. It is, therefore, more important than ever that ethics, transparency, and professionalism explicitly guide research integrity.Despite the clear importance of acquiring a fundamental understanding of clinical trials in the context of health research and innovation, medical training generally fails to cover clinical trial integrity in its curriculum, including it neither at the undergraduate nor at the postgraduate levels. This new book provides a curriculum to address this gap, offering best practice guidelines to improve the quality, openness, and trustworthiness of clinical trials and filling a current void in the market.Key Features: The first book on clinical trial integrity Provides clear guidance on how to ensure probity in peer review, appraisal of trials, and investigation of complaints concerning misconduct in clinical trials Trains and supports researchers globally on how to undertake trials with integrity Ensures that the increasing demand for public documentation of all aspects throughout the lifecycle of a clinical trial can be metThis book is essential reading for master and doctoral students undertaking courses in clinical trials, epidemiology, and medical statistics and an invaluable reference for medical journal editors and peer reviewers, clinicians who recruit patients into trials, pharmaceutical industry professionals, patient and public representatives who engage in clinical trials, systematic reviewers, guideline writers, and funders and regulators of clinical trials.…
Seller Inventory # LU-9781032601229
- Title
- Integrity of Randomized Clinical Trials
- Author
- Khalid S. Khan
- Publisher
- Taylor and Francis Ltd, GB
- Publication year
- 2024
- Condition
- New
- Binding
- Paperback
- Language
- English
- ISBN 10
- 1032601221
- ISBN 13
- 9781032601229
- Item weight
- 390 grams
Today, scientists are expected to be more accountable and transparent than at any other time in history. Globally, the pursuit of knowledge creation enjoys a place of distinction, and the public expects to reap considerable benefits from the innovative contributions made by researchers. It is, therefore, more important than ever that ethics, transparency, and professionalism explicitly guide research integrity.
Despite the clear importance of acquiring a fundamental understanding of clinical trials in the context of health research and innovation, medical training generally fails to cover clinical trial integrity in its curriculum, including it neither at the undergraduate nor at the postgraduate levels. This new book provides a curriculum to address this gap, offering best practice guidelines to improve the quality, openness, and trustworthiness of clinical trials and filling a current void in the market.
Key Features:
- The first book on clinical trial integrity
- Provides clear guidance on how to ensure probity in peer review, appraisal of trials, and investigation of complaints concerning misconduct in clinical trials
- Trains and supports researchers globally on how to undertake trials with integrity
- Ensures that the increasing demand for public documentation of all aspects throughout the lifecycle of a clinical trial can be met
This book is essential reading for master and doctoral students undertaking courses in clinical trials, epidemiology, and medical statistics and an invaluable reference for medical journal editors and peer reviewers, clinicians who recruit patients into trials, pharmaceutical industry professionals, patient and public representatives who engage in clinical trials, systematic reviewers, guideline writers, and funders and regulators of clinical trials.
"Synopsis" may belong to another edition of this title.
About the Author
Khalid S. Khan is Beatriz Galindo Distinguished Investigator at the University of Granada, Spain, and has been Sims Black Fellow of the UK Royal College of Obstetricians and Gynaecologists, Spinoza Professor at the University of Amsterdam, the Netherlands, Fellow of the Pakistani College of Physicians and Surgeons, and Fellow of the UK Higher Education Academy.
"About the title" may belong to another edition of this title.
Shipping rates within U.S.A.
| Item | 8 to 11 business days | 8 to 11 business days |
|---|---|---|
| First item | US$ 0.00 | US$ 0.00 |
Payment methods
Seller's business information
Rarewaves USA
10100 West Sample Road, Ste 101
Coral Springs, FL U.S.A. 33065
Shipping terms
Please note that we do not offer Priority shipping to any country.
We currently do not ship to the below countries:
Afghanistan
Bhutan
Brazil
Brunei Darussalam
Channel Islands
Chile
Israel
Lao
Mexico
Russian Federation
Saudi Arabia
South Africa
Yemen
Please do not attempt to place orders with any of these countries as a ship to address - they will be cancelled.